Ann: Appointment of Non-Executive Director - Dr Robyn Elliott, page-2

Appointment Non-Executive Director – Dr Robyn Elliott
PolyNovo Limited ABN 96 083 866 862
2/320 Lorimer Street Port Melbourne
VIC Australia 3207
P +61 (0) 3 8681 4050 F +61 (0) 3 8681 4099

PolyNovo is delighted to announce the appointment of Dr Robyn Elliott to the board of directors as Non-Executive Director.
Dr Elliott is an accomplished pharmaceutical professional with more than 30 years’ experience at global organisations.
Dr Elliott has a Bachelor of Science (Hons) Chemistry and PhD Inorganic Chemistry from Monash University.
Dr Elliott is currently Senior Director for Strategic Expansion Projects at CSL Behring, previously she was the Managing Director at IDT Australia and commenced her career at DBL Faulding.
Dr Elliott has a proven track record in product development, clinical trials, regulatory affairs, audits, quality management and operational strategy.
Chairman David Williams said; “I am very excited to have Robyn join the team as she perfectly complements our current Board. I worked with her at IDT and know her to be strategic yet hands- on, particularly in relation to plant and regulatory audits. At CSL, her worldwide experience in new plant development and strategy, regulatory affairs and audit will be invaluable to PolyNovo as the company scales its operations globally


CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. Its line of therapies includes products for the treatment of bleeding disorders such as hemophilia and von Willebrand Disease; primary immune deficiencies (PIDD); hereditary angioedema; inherited respiratory disease; and neurological disorders in certain markets. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in the newborn.^[1]
CSL Behring operates the plasma collection network, CSL Plasma.^[2]


Well isn’t this interesting ... Ex CSL joins a minnow like PNV.

Perhaps this minnow isn’t going to be a minnow.